Spots Global Cancer Trial Database for A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Official Title: A Randomized Phase 2 Study of Erlotinib Plus ARQ 197 Versus Erlotinib Plus Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study ID: NCT00777309
Conditions
Study Description
Brief Summary: This is a randomized, placebo-controlled, double blind phase 2 study designed to compare treatment with ARQ 197 plus erlotinib to erlotinib plus placebo in patients with non-small cell lung cancer. The study will enroll patients who have had one prior chemotherapy regimen (other than erlotinib) for NSCLC.
Detailed Description: This is a randomized, placebo-controlled, double blind phase 2 study designed to compare treatment with ARQ 197 plus erlotinib to erlotinib plus placebo in patients with non-small cell lung cancer. The study will enroll patients who have had one prior chemotherapy regimen (other than erlotinib) for NSCLC. The study will evaluate progression-free survival between the two arms. A total of 154 patients will be enrolled.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Burbank, California, United States
, Santa Monica, California, United States
, Torrington, Connecticut, United States
, Jacksonville, Florida, United States
, Atlanta, Georgia, United States
, Chicago, Illinois, United States
, Batesville, Indiana, United States
, Indianapolis, Indiana, United States
, Louisville, Kentucky, United States
, Boston, Massachusetts, United States
, Worcester, Massachusetts, United States
, Charlotte, North Carolina, United States
, Canton, Ohio, United States
, Corpus Christi, Texas, United States
, Dallas, Texas, United States
, Dallas, Texas, United States
, Houston, Texas, United States
, Salt Lake City, Utah, United States
, Gauting, , Germany
, Grosshansdorf, , Germany
, Hamburg, , Germany
, Mainz, , Germany
, Mannheim, , Germany
, Villingen-Schwenningen, , Germany
, Daugavpils, , Latvia
, Riga, , Latvia
, Bialystock, , Poland
, Otwock, , Poland
, Poznan, , Poland
, Szczecin, , Poland
, Torun, , Poland
, Wroclaw, , Poland
Central Clinical Hospital #1, Moscow, , Russian Federation
Central Clinical Hospital #2, Moscow, , Russian Federation
, St. Petersburg, , Russian Federation
, St. Petersburg, , Russian Federation
, St. Petersgurg, , Russian Federation
, Lviv, , Ukraine
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
